Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dark Rider say Dryship tank like Titanic when hit iceberg. Greek gangsta hold alla de cards message board brethren. U want to peer straight uppa azzho den it coming number 1 for U! Just steppa right up an place yo bets!!
Yeah, looking for an investor's response but thanks for your reply all the same.
Valuation: Can anyone speak intelligently to what this might be worth with a Qualcomm settlement alone and then if Apple and LG are added at some point. The survivability of multiple claims in the court order is very bad news for Qualcomm but just not sure of what is realistic number for settlement.
Clarence, no offense but on what basis do you make that statement? Seems like complete conjecture. Not the first time that would be the case on these boards but you present it like it's a fact. Where's the beef?
That could be but he sounds a little angry for your typical short. The reality is no one knows what will happen here. I think it will bounce but I take no issue with the fact that management are tools. But they are tools with something real trying to survive so I get it to some degree. Our biggest hope is the the science outplays their idiocy which is what I'm betting on, plain and simple. If they can follow up the recent news with some FDA communication or they get an upgrade with some nuggets that are essentially "further news" or insight into strategy that will help too. I'm not banking on a partnership announcement but there is certainly more validity to the talk now than at any time in the past several years. If they make further concessions to current note holders that crush the stock (beyond what they have outlined in their filings) and hurt the common I won't understand that at this point and would be a big red flag.
Could be but the financing, as distasteful as it is, shields that to a degree. I'll admit these people have been unsuccessful and have tried to survive by what appear to be scurrilous means but you can't say that isn't the way of most biotechs who don't hit early. You're chasing a scientific home run in most cases and some never hit it. These (DCTH) people may be disorganized, unlucky, bad people and then again they may also have something worth buying by a larger player in the oncology field. Those two factors aren't necessarily mutually exclusive. You can be a complete douche and still have something of value. But I would agree that they are in bad shape unless the news gets a lot better in a hurry in terms of someone making an overt move or there are more specific and significant scientific breakthroughs. If the science is valuable enough they won't have to pursue a partner. Pursuing a partner when it's such a small industry often means you don't have anything real. They'll find you. The results are published. JMO
That's all you can do IMO. I bought it at around .18 average trying to find a lining here and for the simple reason that they have had really good news for the first time in years. If selling abates and there is further strong news it could be an ok trade. If huge news like a partnership with value happened than the financial picture could change dramatically. I'm sort of counting on the first scenario and would be pleasantly surprised (but not totally shocked) by the second one.
I agree with that but they have done some unfortunate financing maneuvers. The fact that they have stated quarterly conversions beginning January 2017 is troubling. They seem to be close to clearing this latest conversion but you have to then be prepared for the next wave and to they wait to convert until Q2, not sure on that one. If they have explosive news like a partnership offer then this could recalibrate in a real way but at some point they will have to get the stock over a buck. I have not seen a good logical case for how this can make a sustained move in light of quarterly conversions therefore the only way I see it happening is major news of partnership or buyout and that is just speculation. Obviously, the latest trial results were very positive and normally would have resulted in a shift but there has been sustained conversion selling into that. Trying to make a case for short term recovery here and we may see that on Friday but hard to say.
Pretty much what I've been thinking glad you posted that. No doubt there could be downside but the shot is relatively cheap so stay tuned!
If that is the case then why make a point about temporarily agreeing to "reduce" the conversion rate to .14 a share? If you don't want to point something out you don't make filings about it. Just from the way the stock acted Friday (and leading into Friday) it seemed like the selling had slowed down to a crawl. But in any case the reduced rate only goes through Thursday of this coming week.
From latest 8K... "On February 22, 2017, Delcath Systems, Inc. (the “Company”) and holders of greater than 55% of the aggregate principal amount (the “Required Holders”) of the Company’s Senior Secured Convertible Notes due December 29, 2017 (the “Notes”) agreed to temporarily reduce the conversion price for conversions at the option of the holders of Notes (the “Conversion Price”) to $0.14 per share of the Company’s common stock, for a period commencing on February 23, 2017 and ending on March 2, 2017 (the “Reduced Conversion Period”)."
What does the minimum conversion price revert to after March 2?
So the question is how much more volume they can or need to unload. Clearly March 2 is the date that there is a hard stop on low level selling. But that date is likely not an accident either. They must have more news coming soon or think that they will. I'm not going to spin any yarns but these people don't set dates by accident or frame things the way they did without thinking about it. If they believe the stock can recover on legit research news rather than an r/s they will take that option. As someone said on another board a $200M market cap isn't absurd for a cancer drug that considerably prolongs life and could lead to better and better outcomes so even if we got to 100M shares outstanding this could be worth $2. They obviously are trying to bank cash in a short window but if the rest of the story is remotely close to what I'm suggesting this shouldn't go down all that much from here because people may sense what is ahead. No guarantees but the news is obviously not "fake" so lets see what happens.
Makes sense to ignore this for now. It definitely should have risen way more than it did today (and yesterday) and it speaks, in my view, to unscrupulous dilution but whatever. Makes little sense to me but obviously the company has a strategy. It may be take in a few million now at a depressed PPS and then r/s which is unfortunate but they will feel little sympathy for day traders or at least that is what management will tell themselves.
Maybe, I guess we'll see over not only today but the next few weeks. GLTY.
What doesn't make sense is if that were really the case you would let it really run and then dilute, not dilute with a 20% gain for mere pennies. Doesn't add up.
There are many people who likely don't get the significance of the news or because they have owned it for so long are using any lift to sell. I think they may be sorry as there is significant research and mainstream articles that discuss what the value of life extension drugs are worth across a broad spectrum of diseases. In this case the outcomes are pretty significant it appears. From the patient perspective it is invaluable because more breakthroughs can come over time which they otherwise wouldn't have which is why it is so valuable. Hate to be simplistic but it provides hope which is worth a tremendous amount monetarily obviously.
Anyone have a quick snapshot of what else they have in late phase testing or other things that could be promising for the company? I think this news alone is worth considerably north of here but would like to hear any other opinions
Yep. Let's see what kind of close we get today.